rs374002995

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate

The NM_020964.3(EPG5):​c.2718+3A>G variant causes a splice region, intron change. The variant allele was found at a frequency of 0.000109 in 1,525,414 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.00012 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00011 ( 0 hom. )

Consequence

EPG5
NM_020964.3 splice_region, intron

Scores

2
Splicing: ADA: 0.7888
2

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 3.89

Publications

0 publications found
Variant links:
Genes affected
EPG5 (HGNC:29331): (ectopic P-granules 5 autophagy tethering factor) This gene encodes a large coiled coil domain-containing protein that functions in autophagy during starvation conditions. Mutations in this gene cause Vici syndrome. [provided by RefSeq, Aug 2015]
EPG5 Gene-Disease associations (from GenCC):
  • Vici syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.43).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EPG5NM_020964.3 linkc.2718+3A>G splice_region_variant, intron_variant Intron 14 of 43 ENST00000282041.11 NP_066015.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EPG5ENST00000282041.11 linkc.2718+3A>G splice_region_variant, intron_variant Intron 14 of 43 1 NM_020964.3 ENSP00000282041.4

Frequencies

GnomAD3 genomes
AF:
0.000118
AC:
18
AN:
152192
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000943
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000235
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000198
AC:
38
AN:
191720
AF XY:
0.000151
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.000248
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000391
Gnomad NFE exome
AF:
0.000294
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000109
AC:
149
AN:
1373222
Hom.:
0
Cov.:
30
AF XY:
0.000115
AC XY:
78
AN XY:
680460
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
28934
American (AMR)
AF:
0.00
AC:
0
AN:
27634
Ashkenazi Jewish (ASJ)
AF:
0.000422
AC:
10
AN:
23680
East Asian (EAS)
AF:
0.00
AC:
0
AN:
34994
South Asian (SAS)
AF:
0.0000426
AC:
3
AN:
70434
European-Finnish (FIN)
AF:
0.000482
AC:
25
AN:
51816
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5528
European-Non Finnish (NFE)
AF:
0.0000959
AC:
103
AN:
1073688
Other (OTH)
AF:
0.000142
AC:
8
AN:
56514
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
6
13
19
26
32
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000118
AC:
18
AN:
152192
Hom.:
0
Cov.:
32
AF XY:
0.000161
AC XY:
12
AN XY:
74356
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41450
American (AMR)
AF:
0.0000655
AC:
1
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5202
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.0000943
AC:
1
AN:
10606
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000235
AC:
16
AN:
68048
Other (OTH)
AF:
0.00
AC:
0
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000245
Hom.:
1
Bravo
AF:
0.000106

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:1
Sep 01, 2017
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.2718+3A>G variant in the EPG5 gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. This variant is not predicted to significantly affect splicing, however in the absence of RNA/functional studies, the actual effect of c.2718+3A>G in this individual is unknown. This substitution occurs at a position that is conserved across species. The c.2718+3A>G variant is observed in 5/6616 (0.075%) alleles from individuals of Finnish background, in the ExAC dataset (Lek et al., 2016). We interpret c.2718+3A>G as a variant of uncertain significance. -

Vici syndrome Uncertain:1
Oct 31, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change falls in intron 14 of the EPG5 gene. It does not directly change the encoded amino acid sequence of the EPG5 protein. It affects a nucleotide within the consensus splice site. This variant is present in population databases (rs374002995, gnomAD 0.04%). This variant has not been reported in the literature in individuals affected with EPG5-related conditions. ClinVar contains an entry for this variant (Variation ID: 451768). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant is not likely to affect RNA splicing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.43
CADD
Uncertain
23
DANN
Benign
0.88
PhyloP100
3.9
Mutation Taster
=61/39
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.79
dbscSNV1_RF
Benign
0.64
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs374002995; hg19: chr18-43505701; API